MedPath

Intranasal dexmedetomidine sedation and analgesia during pediatric emergency room procedures

Phase 4
Not yet recruiting
Conditions
Patients of the pediatric emergency room at Oulu University Hospital with any medical condition requiring a minor painful procedure such as i.v. cannulation or lumbar puncture are asked to join our study if they would seem to benefit from a sedative drug during the procedure.
Registration Number
2024-518816-38-00
Lead Sponsor
Oulu University Hospital
Brief Summary

Our objective is to determine if intranasal dexmedetomidine is a safe and effective sedative drug during small painful procedures in the pediatric emergency room.

Detailed Description

Not available

Recruitment & Eligibility

Status
Authorised, recruitment pending
Sex
Not specified
Target Recruitment
112
Inclusion Criteria

Age 1-12 years

Small procedure (e.g. i.v. cannulation or lumbar puncture)

Presents at the Oulu University Hospital emergency room

Exclusion Criteria

Allergy to dexmedetomidine or any supplementary elements of the dexmedetomidine-solution

II or III degree AV-blockage without pacemaker

Uncontrollable hypotension

Stroke

Critically ill patients who are admitted to the Pediatric Intensive Care Unit

Patients with clear cardiac or respiratory dysfunction

Lowered level of consciousness

Patients with increased risk of apnoeic events due to neurologic or metabolic conditions or extreme obesity

Prior participation to the current study

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Primary end point(s): The primary end point in this study is the success of the procedure at the first attempt.;Timepoint(s) of evaluation of this end point: The success rate of the first attempt of the procedure is evaluated at the end of the first attempt of the procdure.;Main Objective: Our objective is to determine if intranasal dexmedetomidine is a safe and effective sedative drug during small painful procedures in the pediatric emergency room. ;Secondary Objective: The duration of sedative effects of 1µg/kg intranasal dexmedetomidine spray is assessed.
The success of the procedure at the first attempt

The success of the procedure at the first attempt

Secondary Outcome Measures
NameTimeMethod
The duration of the procedure

The duration of the procedure

Parents assessment of the patients comfortability during the procedure

Parents assessment of the patients comfortability during the procedure

Patient's and physician's assessment of the experienced pain with Visual Analog Scale

Patient's and physician's assessment of the experienced pain with Visual Analog Scale

Assessment of pain levels of the patient with FLACC-scores

Assessment of pain levels of the patient with FLACC-scores

Assessment of sedation levels of the patient with Comfort-B-scores

Assessment of sedation levels of the patient with Comfort-B-scores

Duration of crying

Duration of crying

The parents and the emergency room nurses are asked whether they think the patient recieved the experimental drug or placebo

The parents and the emergency room nurses are asked whether they think the patient recieved the experimental drug or placebo

Blood pressure measured by manometer

Blood pressure measured by manometer

Respiratory rate assessed by capnometry

Respiratory rate assessed by capnometry

Oxygen saturation is measured by pulse oxymetry

Oxygen saturation is measured by pulse oxymetry

Heart rate measured by ECG

Heart rate measured by ECG

Trial Locations

Locations (1)

Oulu University Hospital

🇫🇮

Oulu, Finland

Oulu University Hospital
🇫🇮Oulu, Finland
Outi Peltoniemi
Site contact
+35883155837
outi.peltoniemi-ailisto@pohde.fi
© Copyright 2025. All Rights Reserved by MedPath